제노텍 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 이인재, was filed 05 Feb 2026.
제노텍: what insiders have been doing
Every trade that managers of 제노텍 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. From 8 November 2025 to 8 November 2026, the disclosure feed for 제노텍 logged 2 filings by 2 insiders.
Purchases and sales both appear in the filings: 1 purchase (1 insider) and 1 sale (1 insider). The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 1 board member.
With 2 filings in twelve months, the company is quieter than the median of 7 filings across the 2,657 companies we follow on the same exchange. Over the whole record (from 2022), the tally stands at 8 purchases and 2 sales.
The most recent open-market purchase was published on 5 February 2026, 278 days ago.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -17.3%Entry 1,688.00 · Close at T+365 1,396.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 202,000 sharesKRXDART:20260209000690
- 10,500 sharesShareKRXDART:20260205000240Canonical exit: 6 May 2026 (T+90)
- 200,000 sharesKRXDART:20240905000410
- 108,088 sharesKRXDART:20240816000211Canonical exit: 7 Nov 2024 (T+90)
- ShareKRXDART:20240814003498Canonical exit: 7 Nov 2024 (T+90)
- 5,000 shares@ ₩1,726.0062.5% of flowShareKRXDART:20240314000867Canonical exit: 6 Jun 2024 (T+90)
- 3,088 shares@ ₩1,678.691737.5% of flowShareKRXDART:20240205000106Canonical exit: 28 Apr 2024 (T+90)
- ShareKRXDART:20231005000129
- 108,088 sharesKRXDART:20230726000249Canonical exit: 17 Oct 2023 (T+90)
- 34,002 sharesShareKRXDART:20230215000699Canonical exit: 14 May 2023 (T+90)
- 13,799 sharesShareKRXDART:20230215000746Canonical exit: 14 May 2023 (T+90)
- ●Executives0DART
12 of 12 declarations
About 제노텍
Genotech is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the medical field.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
